Evidence map›Paper›PMID 23912651›Full record

ArticleMolecular & cellular proteomics : MCP2013

Exploring the N-glycosylation pathway in Chlamydomonas reinhardtii unravels novel complex structures.

Elodie Mathieu-Rivet, Martin Scholz, Carolina Arias, Flavien Dardelle, Stefan Schulze, François Le Mauff, Gavin Teo, Ana Karina Hochmal, Amaya Blanco-Rivero, Corinne Loutelier-Bourhis and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Unwrapping the Ciliary Coat: High-Resolution Structure and Function of the Ciliary Glycocalyx.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. An overview of proteinFrontiers in plant science · 2025
    Review
  6. Article
  7. The Diversity of N-Glycans ofFoods (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Plants (Basel, Switzerland) · 2022
    Review
  13. Article
  14. Article
  15. Towards understanding the extensive diversity of protein N-glycan structures in eukaryotes.Biological reviews of the Cambridge Philosophical Society · 2022
    Review
  16. Article
  17. Review
  18. Crystallographic analysis and phasing of iron-assimilating protein 1 (FEA1) from Chlamydomonas reinhardtii.Acta crystallographica. Section F, Structural biology communications · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 4 countries.

Elodie Mathieu-RivetUniversité de Rouen, Laboratoire Glyco-MEV, EA 4358, Institut de Recherche et d'Innovation Biomédicale (IRIB), 76821 Mont-Saint-Aignan Cedex, France;
Martin Scholz
Carolina Arias
Flavien Dardelle
Stefan Schulze
François Le Mauff
Gavin Teo
Ana Karina Hochmal
Amaya Blanco-Rivero
Corinne Loutelier-Bourhis
Marie-Christine Kiefer-Meyer
Christian Fufezan
Carole Burel
Patrice Lerouge
Flor Martinez
Muriel Bardor
Michael Hippler
University of Münster · DELaboratoire de Glycobiologie et Matrice Extracellulaire VégétaleUniversité de Rouen Normandie · FRLaboratoire Physiologie Cellulaire & Végétale · FRAgency for Science, Technology and Research · SGBioprocessing Technology Institute · SGGénétique Moléculaire Génomique Microbiologie · FRInstitut National des Sciences Appliquées Rouen Normandie · FRUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlamydomonas reinhardtii is a green unicellular eukaryotic model organism for studying relevant biological and biotechnological questions. The availability of genomic resources and the growing interest in C. reinhardtii as an emerging cell factory for the industrial production of biopharmaceuticals require an in-depth analysis of protein N-glycosylation in this organism. Accordingly, we used a comprehensive approach including genomic, glycomic, and glycoproteomic techniques to unravel the N-glycosylation pathway of C. reinhardtii. Using mass-spectrometry-based approaches, we found that both endogenous soluble and membrane-bound proteins carry predominantly oligomannosides ranging from Man-2 to Man-5. In addition, minor complex N-linked glycans were identified as being composed of partially 6-O-methylated Man-3 to Man-5 carrying one or two xylose residues. These findings were supported by results from a glycoproteomic approach that led to the identification of 86 glycoproteins. Here, a combination of in-source collision-induced dissodiation (CID) for glycan fragmentation followed by mass tag-triggered CID for peptide sequencing and PNGase F treatment of glycopeptides in the presence of (18)O-labeled water in conjunction with CID mass spectrometric analyses were employed. In conclusion, our data support the notion that the biosynthesis and maturation of N-linked glycans in the endoplasmic reticulum and Golgi apparatus occur via a GnT I-independent pathway yielding novel complex N-linked glycans that maturate differently from their counterparts in land plants.

Indexed as

Algal ProteinsAmino Acid SequenceCarbohydrate SequenceChlamydomonas reinhardtiiEndoplasmic ReticulumGenomicsGlycomicsGlycoproteinsGlycosylationGolgi ApparatusMetabolic Networks and PathwaysMethylationMolecular Sequence DataMolecular StructureN-AcetylglucosaminyltransferasesPolysaccharidesAlgal Proteinsalpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase IGlycoproteinsN-AcetylglucosaminyltransferasesPolysaccharidesXylose

Identifiers

PMID23912651
PMCPMC3820931
OpenAlexW2133109758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.